SRDX - רווח נקי למניה (EPS TTM) Surmodics Corp

The TTM EPS history of Surmodics, Inc. (SRDX) demonstrates the efficiency of catheter coating logistics, where supply diversification supports high profitability. -1.24 serves as the current parameter value, underscoring the company's status as a trusted B2B developer of safe surface modifications. Financial stability is based on a balance of licensing royalties and proprietary sales within the vascular surgery segment.

To select high-quality assets, an investor must compare market value with the actual efficiency of capital management. This metric is calculated as the ratio of total annual net income to the number of shares, which allows for an assessment of Surmodics, Inc. (SRDX) patent monetization under strict FDA regulation, filtering out market noise via a 12-month net income per share chart.